Pharmacology, Toxicology and Pharmaceutical Science
Methotrexate
100%
Randomized Controlled Trial
50%
Proliferative Diabetic Retinopathy
50%
Aflibercept
50%
Anakinra
50%
Ciclosporin
50%
Myositis
50%
Rheumatoid Arthritis
50%
Controlled Clinical Trial
50%
Inflammatory Arthritis
50%
Monotherapy
33%
Placebo
30%
Retina Neovascularization
20%
Glucocorticoid
20%
Adverse Event
14%
Intravitreal Administration
10%
Diabetes Mellitus
10%
Vasculotropin B
10%
Homo sapiens
10%
Combination Therapy
10%
Clinical Feature
10%
Placental Growth Factor
10%
Clinical Trial
10%
Vasculotropin Inhibitor
10%
Diseases
10%
Visual Impairment
10%
Vasculotropin A
10%
Medicine and Dentistry
Proliferative Diabetic Retinopathy
50%
Drug Screening
50%
Controlled Clinical Trial
50%
Chronic Pain
50%
Aflibercept
50%
Cost-Effectiveness Analysis
30%
Clinical Trial
22%
Laser Coagulation
20%
Retina Neovascularization
20%
Complex Regional Pain Syndrome
12%
Patient Population
12%
Clinical Trial Design
12%
Adverse Event
10%
Human Subject
10%
Randomized Controlled Trial
10%
Visual Impairment
10%
Vasculotropin B
10%
Vasculotropin A
10%
Low Level Laser Therapy
10%
Placental Growth Factor
10%
Diabetes Mellitus
10%
Intravitreal Administration
10%
Visual Acuity
10%
Vasculotropin Inhibitor
10%
Adverse Effect
10%
Neuroscience
Myositis
50%
Immunosuppression
50%
Ciclosporin
50%
Methotrexate
50%
Randomized Controlled Trial
40%
Placebo
30%
Glucocorticoid
20%
Muscle Disorder
10%
